Suraksha Diagnostic Ltd Stock Price Today (NSE: SURAKSHA)
Fundamental Score
Suraksha Diagnostic Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Suraksha Diagnostic Ltd share price today is ₹290.25, up +3.04% on NSE/BSE as of 19 June 2026. Suraksha Diagnostic Ltd (SURAKSHA) is a Small-cap company in the Healthcare Service Provider sector with a market capitalisation of ₹1.53K (Cr). The 52-week high for SURAKSHA share price is ₹352.50 and the 52-week low is ₹224.10. At a P/E ratio of 48.05x, SURAKSHA is currently trading above its industry average P/E of 39.28x. The company has a Return on Equity (ROE) of 16.46% and a debt-to-equity ratio of 0.51.
Suraksha Diagnostic Ltd Share Price Chart — NSE/BSE Historical Performance
Suraksha Diagnostic Ltd share price chart: 1.61% return over the past month. 52-week high ₹352.50, 52-week low ₹224.10.
Suraksha Diagnostic Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹278.15 | ₹301.00 | ₹278.15 | ₹290.25 | 23.21K (Cr) | |
| ₹286.00 | ₹289.05 | ₹280.00 | ₹281.70 | 18.66K (Cr) | |
| ₹292.10 | ₹292.10 | ₹284.00 | ₹285.80 | 16.81K (Cr) | |
| ₹295.50 | ₹298.50 | ₹287.05 | ₹289.60 | 38.57K (Cr) | |
| ₹300.95 | ₹306.00 | ₹295.00 | ₹295.50 | 15.69K (Cr) | |
| ₹310.00 | ₹312.90 | ₹297.90 | ₹298.50 | 49.01K (Cr) | |
| ₹320.10 | ₹322.30 | ₹291.10 | ₹313.20 | 1.43L (Cr) | |
| ₹305.05 | ₹324.95 | ₹305.05 | ₹320.10 | 1.74L (Cr) | |
| ₹299.50 | ₹308.40 | ₹296.40 | ₹305.05 | 56.54K (Cr) | |
| ₹299.55 | ₹308.00 | ₹298.05 | ₹299.50 | 17.66K (Cr) |
Suraksha Diagnostic Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹286.00 | ₹301.00 | ₹278.15 | ₹290.25 | +1.49% | |
| ₹280.00 | ₹324.95 | ₹280.00 | ₹285.80 | +2.07% | |
| ₹230.99 | ₹292.10 | ₹230.99 | ₹283.95 | +22.93% | |
| ₹240.00 | ₹276.00 | ₹224.10 | ₹227.95 | -5.02% | |
| ₹270.20 | ₹293.95 | ₹265.00 | ₹271.45 | +0.46% | |
| ₹270.55 | ₹281.65 | ₹251.50 | ₹265.95 | -1.70% | |
| ₹290.75 | ₹299.90 | ₹264.05 | ₹269.65 | -7.26% | |
| ₹315.15 | ₹329.00 | ₹286.00 | ₹292.70 | -7.12% | |
| ₹297.00 | ₹325.90 | ₹284.20 | ₹317.95 | +7.05% | |
| ₹296.80 | ₹333.00 | ₹295.00 | ₹298.35 | +0.52% | |
| ₹301.50 | ₹324.25 | ₹285.75 | ₹298.30 | -1.06% | |
| ₹325.20 | ₹335.05 | ₹297.00 | ₹300.95 | -7.46% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Suraksha Diagnostic Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Suraksha Diagnostic Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of SURAKSHA across key market metrics for learning purposes.
Positive Indicators
9 factors identified
Strong Return on Equity (16.46%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (17.84%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (26.87%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Strong Revenue Growth (17.95%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Strong Profit Growth Track Record (16.38% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Strong Interest Coverage (5.39x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Cash Generation (₹102.08 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Strong Institutional Confidence (FII+DII: 35.71%)
Observation: Significant professional investor participation.
Analysis: High institutional holding often signals thorough due diligence.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
4 factors identified
Premium Valuation Risk (P/E: 48.05x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-13.06%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Weak Earnings Growth (-50.98% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Suraksha Diagnostic Ltd vs Healthcare Service Provider Peers
Peer Comparison - Healthcare Service Provider
Compare Suraksha Diagnostic Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Suraksha Diagnostic LtdSuraksha Diagno...Selected✓ SURAKSHA • 544293 | 47.1/100 | ₹290.25₹290 | ₹1534.08₹1534.08 | 48.05Average 48.0 Average | 16.46%Good 16.46% Good | 17.84%Good 17.84% Good | 0.51Good 0.5 Good | 16.38%Excellent 16.38% Excellent | 9.86%Good 9.86% Good | 0.00% |
Dr Lal PathLabs LtdDr Lal PathLabs... LALPATHLAB • 539524 | 64.3/100 | ₹1617.20₹1617 | ₹25557.40₹25557.40 | 47.83Average 47.8 Average | 24.30%Excellent 24.30% Excellent | 28.88%Excellent 28.88% Excellent | 0.07Excellent 0.1 Excellent | 16.69%Excellent 16.69% Excellent | 13.09%Good 13.09% Good | 0.79% |
Vijaya Diagnostic Centre LtdVijaya Diagnost... VIJAYA • 543350 | 53.7/100 | ₹1261.40₹1261 | ₹10272.45₹10272.45 | 67.39Average 67.4 Average | 19.00%Good 19.00% Good | 20.91%Excellent 20.91% Excellent | 0.42Excellent 0.4 Excellent | 18.97%Excellent 18.97% Excellent | 15.00%Excellent 15.00% Excellent | 0.20% |
Metropolis Healthcare LtdMetropolis Heal... METROPOLIS • 542650 | 48.9/100 | ₹536.15₹536 | ₹10124.28₹10124.28 | 63.98Average 64.0 Average | 11.53%Average 11.53% Average | 14.66%Average 14.66% Average | 0.14Excellent 0.1 Excellent | -0.56%Poor -0.56% Poor | 9.22%Good 9.22% Good | 0.20% |
Thyrocare Technologies LtdThyrocare Techn... THYROCARE • 539871 | 40.5/100 | ₹512.15₹512 | ₹7724.80₹7724.80 | 60.48Average 60.5 Average | 16.15%Good 16.15% Good | 24.78%Excellent 24.78% Excellent | 0.05Excellent 0.1 Excellent | -0.64%Poor -0.64% Poor | 9.62%Good 9.62% Good | 1.44% |
Krsnaa Diagnostics LtdKrsnaa Diagnost... KRSNAA • 543328 | 39.6/100 | ₹538.45₹538 | ₹2626.09₹2626.09 | 30.73Average 30.7 Average | 9.29%Poor 9.29% Poor | 12.52%Average 12.52% Average | 0.30Excellent 0.3 Excellent | 22.05%Excellent 22.05% Excellent | 21.41%Excellent 21.41% Excellent | 0.34% |
3B Blackbio Diagnostics Ltd3B Blackbio Dia... 3BBLACKBIO • 532067 | 66.1/100 | ₹1225.40₹1225 | ₹1080.56₹1080.56 | 22.01Average 22.0 Average | 19.40%Good 19.40% Good | 25.75%Excellent 25.75% Excellent | 0.00Excellent 0.0 Excellent | 44.03%Excellent 44.03% Excellent | 27.29%Excellent 27.29% Excellent | 0.32% |
One Global Service Provider IncOne Global Serv... ONEGLOBAL • 514330 | 69.5/100 | ₹424.15₹424 | ₹1070.08₹1070.08 | 24.39Average 24.4 Average | 42.31%Excellent 42.31% Excellent | 56.38%Excellent 56.38% Excellent | 0.00Excellent 0.0 Excellent | 128.82%Excellent 128.82% Excellent | — — | 0.00% |
Sastasundar Ventures LtdSastasundar Ven... SASTASUNDR • 533259 | 40.3/100 | ₹313.95₹314 | ₹1042.27₹1042.27 | — — | 4.63%Poor 4.63% Poor | -1.33%Poor -1.33% Poor | 0.01Excellent 0.0 Excellent | 23.31%Excellent 23.31% Excellent | 24.47%Excellent 24.47% Excellent | 0.00% |
46.5/100 | ₹233.90₹234 | ₹826.72₹826.72 | 30.47Average 30.5 Average | 27.08%Excellent 27.08% Excellent | 28.85%Excellent 28.85% Excellent | 0.48Excellent 0.5 Excellent | — — | — — | 0.00% | |
Choksi Imaging LtdChoksi Imaging ... CHOKSI • 526546 | 45.3/100 | ₹126.35₹126 | ₹92.81₹92.81 | 55.91Average 55.9 Average | 6.63%Poor 6.63% Poor | 9.20%Poor 9.20% Poor | 1.18Average 1.2 Average | 32.13%Excellent 32.13% Excellent | 8.21%Good 8.21% Good | 0.00% |
Top Healthcare Service Provider Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Dr Lal PathLabs Ltd share price25557.40 Cr
- Vijaya Diagnostic Centre Ltd share price10272.45 Cr
- Metropolis Healthcare Ltd share price10124.28 Cr
- Thyrocare Technologies Ltd share price7724.80 Cr
- Krsnaa Diagnostics Ltd share price2626.09 Cr
Suraksha Diagnostic Ltd PE Ratio History
Historical price-to-earnings ratio for SURAKSHA — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹5.97 | ₹269.65 | 45.2x |
| FY 2024 | ₹4.54 | ₹375.65 | 82.8x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Suraksha Diagnostic Ltd Quarterly Performance
Latest quarterly metrics for SURAKSHA — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
17.95%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-13.06%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
9.86%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
16.38%
Compounded annual net profit growth over 5 years
Suraksha Diagnostic Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for SURAKSHA — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Suraksha Diagnostic Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Suraksha Diagnostic Ltd (SURAKSHA) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Suraksha Diagnostic Ltd
About SURAKSHA (Suraksha Diagnostic Ltd)
Suraksha Diagnostic Ltd is a comprehensive healthcare service provider dedicated to delivering accurate, reliable, and timely diagnostic testing to patients across India. As a trus...ted name in the diagnostic landscape, Suraksha is committed to utilizing state-of-the-art technology and employing highly skilled professionals to ensure the highest standards of quality. From routine blood tests to advanced imaging, Suraksha offers a broad spectrum of diagnostic services to cater to the diverse needs of its patients and healthcare partners. Driven by a patient-centric approach, Suraksha aims to empower individuals to make informed decisions about their health through accessible and affordable diagnostic solutions. Suraksha Diagnostic's commitment extends beyond simply providing testing services. They are dedicated to employing cutting-edge methodologies and sophisticated equipment to analyze biological samples and produce detailed images. Specifically, the pathology department examines blood, tissues, and other body fluids using a range of techniques, from traditional staining methods to advanced molecular diagnostics. The radiology department utilizes sophisticated imaging equipment, like MRI and CT scans, to provide detailed views of internal organs and structures. This dedication to technology and expertise allows Suraksha to play a crucial role in early disease detection, accurate diagnosis, and effective treatment planning. In addition to its technical prowess, Suraksha Diagnostic prides itself on its unwavering commitment to ethical practices, patient safety, and customer satisfaction. The company adheres to stringent quality control measures and participates in external quality assurance programs to ensure the accuracy and reliability of its test results. Suraksha strives to create a welcoming and comfortable environment for its patients, with a focus on personalized attention and compassionate care. By combining cutting-edge technology with a human touch, Suraksha Diagnostic is committed to being a trusted partner in promoting the health and well-being of the communities it serves.
Company Details
Key Leadership
SURAKSHA Share Price: Frequently Asked Questions
What is the current share price of Suraksha Diagnostic Ltd?
Suraksha Diagnostic Ltd (SURAKSHA) trades at ₹290.25 on NSE and BSE. Market cap ₹1.53K (Cr). Educational data only.
What is the P/E ratio of Suraksha Diagnostic Ltd?
Suraksha Diagnostic Ltd has a P/E of 48.05x vs industry average 39.28x.
What is the Bull Run score for Suraksha Diagnostic Ltd?
Suraksha Diagnostic Ltd has a Bull Run score of 47.1/100 based on 25+ financial parameters.
Does Suraksha Diagnostic Ltd pay dividends?
Suraksha Diagnostic Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Suraksha Diagnostic Ltd?
Suraksha Diagnostic Ltd has ROE of 16.46%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Suraksha Diagnostic Ltd?
Suraksha Diagnostic Ltd has debt-to-equity of 0.51.
Is Suraksha Diagnostic Ltd a good investment?
Bull Run gives Suraksha Diagnostic Ltd a score of 47.1/100. This is not investment advice — consult a SEBI-registered advisor.